This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PharMerica Schedules Conference Call To Discuss Preliminary Guidance For Fiscal Year 2014

PharMerica Corporation (NYSE:PMC), a national provider of institutional pharmacy, specialty infusion, hospital pharmacy management, and oncology pharmacy and care management services, today announced that it will issue a press release regarding its preliminary guidance for fiscal year 2014 on Friday, January 10, 2014. The Company will also host a conference call on Friday, January 10, 2014 at 8:30 a.m. Eastern Time.

Individuals wishing to participate in the conference call should call (866) 515-2910 or (617) 399-5124, passcode 28918065. For those unable to join the call, a replay will be available through January 17, 2014 by dialing (888) 286-8010 or (617) 801-6888, pass code 21486507. The call will also broadcast live over the Internet and can be accessed on the “For Investors” tab of the Company’s website, www.pharmerica.com, under “Webcasts and Presentations.”

About PharMerica

PharMerica Corporation is a leading institutional pharmacy services company that services healthcare facilities in the United States, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the only national oncology pharmacy and care management platform in the U.S. PharMerica operates 95 institutional pharmacies and 12 specialty infusion centers in 45 states. PharMerica’s customers are institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care and other long-term alternative care providers.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,985.15 -85.25 -0.47%
S&P 500 2,097.80 -16.69 -0.79%
NASDAQ 4,950.6330 -66.2960 -1.32%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs